2'-methyl-[1,4']bipiperidine | 927018-27-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 2'-methyl-[1,4']bipiperidine
• 英文别名: 2'-Methyl-[1,4']bipiperidinyl；2-methyl-4-piperidin-1-ylpiperidine
• CAS: 927018-27-7
• 化学式: C₁₁H₂₂N₂
• 分子量: 182.309
• InChiKey: KAYPTZAOZJVDRG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  15.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1'-tert-Butoxycarbonyl-[1,4']-Bipiperidine 、 5-溴吡啶-2-羧酸甲酯 、 硫酸二甲酯 生成 2'-methyl-[1,4']bipiperidine
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• [EN] SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS<br/>[FR] CARBOXAMIDES N-HÉTÉROCYCLIQUES SUBSTITUÉS, SATURÉS ET INSATURÉS ET COMPOSÉS APPARENTÉS POUR LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES MÉDICAUX
  申请人：BIAL BIOTECH INVEST INC

  公开号：WO2021055630A1

  公开（公告）日：2021-03-25

  The invention provides substituted, saturated and unsaturated N-heterocyclic carboxamides and related compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., cancer, lysosomal storage disorder, neurodegenerative disorder, inflammatory disorder, in a patient.

  这项发明提供了替代的、饱和的和不饱和的N-杂环羧酰胺及相关化合物，含有这些化合物的组合物，医疗工具包，以及使用这些化合物和组合物治疗患者的医疗疾病，例如癌症、溶酶体贮积疾病、神经退行性疾病、炎症性疾病等的方法。
• Novel gamma secretase inhibitors
  申请人：Schering-Plough Corporation

  公开号：US20040171614A1

  公开（公告）日：2004-09-02

  This invention discloses novel gamma secretase inhibitors of the formula: 1 wherein: R 1 is a substituted aryl or substituted heteroaryl group; R 2 is an R 1 group, alkyl, —XC(O)Y, alkylene-XC(O)Y, cycloalkylene-X-C(O)—Y, —CH—X—C(O)—NR 3 —Y or —CH—X—C(O)—Y, wherein X and Y are as defined herein; each R 3 and each R 3A are independently H, or alkyl; R 11 is aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, or alkoxyalkyl. Also disclosed is a method of treating Alzheimer's Disease using one or more compounds of the invention.

  这项发明揭示了一种新颖的伽玛分泌酶抑制剂，其化学式为：其中：R1为取代芳基或取代杂芳基；R2为R1基团、烷基、—XC(O)Y、烷基烯-XC(O)Y、环烷基烯-X-C(O)—Y、—CH—X—C(O)—NR3—Y或—CH—X—C(O)—Y，其中X和Y如本文中所定义；每个R3和每个R3A独立地为H或烷基；R11为芳基、杂芳基、烷基、环烷基、芳基烷基、芳基环烷基、杂芳基烷基、杂芳基环烷基、芳基杂环烷基或烷氧基烷基。还公开了使用该发明的一个或多个化合物治疗阿尔茨海默病的方法。
• [EN] GAMMA SECRETASE INHIBITORS<br/>[FR] INHIBITEURS DE LA GAMMA-SECRETASE
  申请人：SCHERING CORP

  公开号：WO2003066592A1

  公开（公告）日：2003-08-14

  This invention discloses novel gamma secretase inhibitors of the formula:(Chemical formula should be inserted here as it appears on abstract in paper form)wherein: R1 is a substituted aryl or substituted heteroaryl group; R2 is an R1 group, alkyl, -X(CO)Y, or alkylene-X(CO)Y wherein X and Y are as defined herein; each R3 and each R3A are independently H, or alkyl; R11 is aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, or alkoxyalkyl. Also disclosed is a method of treating Alzheimer s Disease using one or more compounds of the invention.

  本发明公开了一种新型γ-分泌酶抑制剂，其化学式为：（化学式应按照论文形式插入此处） 其中：R1是取代芳基或取代杂环基；R2是R1基团，烷基，-X（CO）Y，或烷基-X（CO）Y，其中X和Y如定义所述；每个R3和每个R3A独立地是氢或烷基；R11是芳基，杂环基，烷基，环烷基，芳基烷基，芳基环烷基，杂环基烷基，杂环基环烷基，芳基杂环环烷基或烷氧基烷基。本发明还公开了使用本发明的一种或多种化合物治疗阿尔茨海默病的方法。
• Novel Gamma Secretase inhibitors
  申请人：Pissarnitski Dmitri

  公开号：US20060100427A1

  公开（公告）日：2006-05-11

  This invention discloses novel gamma secretase inhibitors of the formula: wherein: R 1 is a substituted aryl or substituted heteroaryl group; R 2 is an R 1 group, alkyl, —X(CO)Y, or alkylene-X(CO)Y wherein X and Y are as defined herein; each R 3 and each R 3A are independently H, or alkyl; R 11 is aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, or alkoxyalkyl. Also disclosed is a method of treating Alzheimer's Disease using one or more compounds of the invention.

  本发明公开了新型伽马分泌酶抑制剂的公式：其中：R1是取代芳基或取代杂环芳基基团；R2是R1基团，烷基，-X（CO）Y，或烷基-X（CO）Y，其中X和Y如本文所定义；每个R3和每个R3A独立地是H或烷基；R11是芳基，杂环芳基，烷基，环烷基，芳基烷基，芳基环烷基，杂环芳基烷基，杂环芳基环烷基，芳基杂环环烷基或烷氧基烷基。还公开了使用本发明中的一种或多种化合物治疗阿尔茨海默病的方法。
• RUBBER COMPOSITION AND PNEUMATIC TIRE
  申请人：Sumitomo Rubber Industries, Ltd.

  公开号：EP2740759A1

  公开（公告）日：2014-06-11

  Provided are: a rubber composition that improves fuel economy, wet grip performance, and dry grip performance together while maintaining the balance between them; and a pneumatic tire whose component (particularly tread) includes the rubber composition. The invention relates to a rubber composition containing: a rubber component containing a copolymer; and a silica, wherein the copolymer is obtained by copolymerization of 1,3-butadiene, styrene, and a compound of formula (I) below, has an amino group at a first chain end and a functional group containing at least one atom selected from the group consisting of nitrogen, oxygen, and silicon at a second chain end, and has a Mw of 1.0×105-2.5×106, and the silica has an average length W1 between branched particles Z-Z inclusive of the branched particles Zs of 30-400 nm, wherein the branched particles Zs are each adjacent to at least three particles; wherein R1 represents a C1-C10 hydrocarbon group.

  本发明提供了：一种橡胶组合物，可同时提高燃油经济性、湿抓地力性能和干抓地力性能，同时保持三者之间的平衡；以及一种充气轮胎，其部件（尤其是胎面）包括该橡胶组合物。本发明涉及一种橡胶组合物，其中包含：含有共聚物的橡胶组分；以及白炭黑，其中共聚物由 1，3-丁二烯、苯乙烯和下式（I）化合物共聚得到，在第一链端具有氨基，在第二链端具有含有至少一个选自氮、氧和硅组成的组中的原子的官能团，且 Mw 为 1.0×105-2.5×106，且该二氧化硅在包括支化颗粒 Zs 在内的支化颗粒 Z-Z 之间的平均长度 W1 为 30-400 nm，其中支化颗粒 Zs 每个至少与三个颗粒相邻； 其中 R1 代表 C1-C10 烃基。